{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T20:10:14Z","timestamp":1726258214135},"reference-count":22,"publisher":"American Society of Consultant Pharmacists","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["sr care pharm"],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:p>This case study reviews the pharmacotherapy of a resident in a long-term care facility being treated for poststroke seizure, hallucinations, and dementia, a geriatric syndrome that is both common in regard to its prevalence and severe in regard to its impact on the individual, families, caregivers, and health care system. This case describes the past medical history of an older resident in a skilled nursing facility that was receiving pharmacological therapy for auditory hallucinations and for poststroke seizure prophylaxis, was noted to be having side effects from drug therapy, and how the nursing staff communicated with the consultant pharmacist to resolve these issues.<\/jats:p>","DOI":"10.4140\/tcp.n.2021.645","type":"journal-article","created":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T04:40:15Z","timestamp":1638592815000},"page":"645-651","source":"Crossref","is-referenced-by-count":0,"title":["Deprescribing to Resolve Oversedation and Confusion in an Older Person Treated for Auditory Hallucinations and Poststroke Seizure Prophylaxis"],"prefix":"10.4140","volume":"36","author":[{"given":"Mark","family":"Branum","sequence":"first","affiliation":[{"name":"Adjunct Assistant Professor, Drake University, Des Moines, Iowa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2625","reference":[{"key":"ref1","first-page":"4255","article-title":"Epilepsy in the elderly: some clinical and pharmacotherapeutic aspects.","year":"2001","journal-title":"Epilepsia."},{"issue":"6","key":"ref2","first-page":"e98","article-title":"American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research. Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals from the American Heart Association\/American Stroke Association.","volume":"47","year":"2016","journal-title":"Stroke."},{"issue":"3","key":"ref3","first-page":"507","article-title":"In the treatment of epilepsy levetiracetam.","volume":"4","year":"2008","journal-title":"Neuropsychiatr Dis Treat."},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s40263-016-0384-x","article-title":"Synaptic vesicle glycoprotein 2A ligands in the treatment of epilepsy and beyond.","volume":"30","year":"2016","journal-title":"CNS Drugs."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/j.1528-1167.2006.01132.x","article-title":"Prolonged exposure to levetiracetam reveals a presynaptic effect on neurotransmission.","volume":"48","year":"2007","journal-title":"Epilepsia."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1152\/jn.00279.2011","article-title":"A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam.","volume":"106","year":"2011","journal-title":"J Neurophysiol."},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1528-1157.2000.tb04605.x","article-title":"Efficacy and tolerability of levetiracetam 3000 mg\/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group.","volume":"41","year":"2000","journal-title":"Epilepsia."},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.seizure.2004.12.006","article-title":"Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up study.","volume":"14","year":"2005","journal-title":"Seizure."},{"key":"ref9","first-page":"36","article-title":"Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial.","volume":"55","year":"2000","journal-title":"Neurology."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1528-1157.2000.tb00323.x","article-title":"Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group.","volume":"41","year":"2000","journal-title":"Epilepsia."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1212\/01.wnl.0000268699.34614.d3","article-title":"Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy.","volume":"69","year":"2007","journal-title":"Neurology."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/01.wnl.0000252941.50833.4a","article-title":"Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.","volume":"68","year":"2007","journal-title":"Neurology."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/01.wnl.0000297512.18364.40","article-title":"Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures.","volume":"70","year":"2008","journal-title":"Neurology."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0024-3205(00)00911-5","article-title":"Binding of antipsychotic drugs to human brain receptors: focus on newer generation compounds.","volume":"68","year":"2000","journal-title":"Life Sci."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0924-977X(00)00133-4","article-title":"D2 and 5HT2A receptor occupancy of different doses of quetiapine in schizophrenia: a PET study.","volume":"11","year":"2001","journal-title":"Eur Neuropsychopharmacol."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.","volume":"353","year":"2005","journal-title":"N Engl J Med."},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1017\/S1092852900017089","article-title":"Selective histamine H1 antagonism: novel hypnotic and pharmacologic actions challenge classical notions of antihistamines.","volume":"13","year":"2008","journal-title":"CNS Spectr."},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.7162\/S1809-97772012000300004","article-title":"Auditory hallucinations in tinnitus patients: emotional relationships and depression.","volume":"16","year":"2012","journal-title":"Int Arch Otorhinolaryngol."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1874205X01711010011","article-title":"\u201cDoctor, I hear music\u201d: a brief review about musical hallucinations.","volume":"11","year":"2017","journal-title":"Open Neurol J."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1478-4491-11-19","article-title":"Ten principles of good interdisciplinary team work.","volume":"11","year":"2013","journal-title":"Hum Resour Health."},{"issue":"2","key":"ref21","first-page":"9","article-title":"Health care professional development: working as a team to improve patient care.","volume":"14","year":"2014","journal-title":"Sudan J Paediatr."},{"article-title":"Chapter 33: Professional communication and team collaboration.","volume-title":"Patient Safety and Quality: An Evidence-Based Handbook for Nurses.","year":"2008","key":"ref22"}],"container-title":["The Senior Care Pharmacist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ascp\/tscp\/2021\/00000036\/00000012\/art00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T19:27:55Z","timestamp":1726255675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.4140\/TCP.n.2021.645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,1]]}},"alternative-id":["2639-9636(20211201)36:12L.645;1-"],"URL":"https:\/\/doi.org\/10.4140\/tcp.n.2021.645","relation":{},"ISSN":["2639-9636"],"issn-type":[{"type":"print","value":"2639-9636"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}